{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:46:55Z","timestamp":1787244415593,"version":"build-2736575974"},"reference-count":22,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T00:00:00Z","timestamp":1716768000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014630","name":"Government of France Ministry of Health and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014630","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.ando.2024.05.024","type":"journal-article","created":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T15:16:30Z","timestamp":1716909390000},"page":"276-283","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Genetic predisposition to pheochromocytoma and paraganglioma: 21 years of experience in the field"],"prefix":"10.1016","volume":"85","author":[{"given":"Catherine","family":"Cardot-Bauters","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Christine","family":"Vantyghem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Do Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Desailloud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Joubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Coppin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Francoise","family":"Odou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Pigny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ando.2024.05.024_bib0115","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1097\/HJH.0000000000002438","article-title":"Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension","volume":"38","author":"Lenders","year":"2020","journal-title":"J Hypertens"},{"key":"10.1016\/j.ando.2024.05.024_bib0120","doi-asserted-by":"crossref","first-page":"R65","DOI":"10.1530\/EO-22-0044","article-title":"Pheochromocytoma and paraganglioma: germline genetics and hereditary syndomes","volume":"2","author":"Turin","year":"2022","journal-title":"Endocr Oncol"},{"key":"10.1016\/j.ando.2024.05.024_bib0125","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1136\/jmg.40.6.e75","article-title":"Hereditary phaeochromocytomas and paragangliomas: a study of five susceptibility genes","volume":"40","author":"Bauters","year":"2003","journal-title":"J Med Genet"},{"key":"10.1016\/j.ando.2024.05.024_bib0130","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.ando.2024.05.024_bib0135","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jmoldx.2019.01.005","article-title":"Optimization of next-generation sequencing technologies for von Hippel Lindau (VHL) mosaic mutation detection and development of confirmation methods","volume":"21","author":"Coppin","year":"2019","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.ando.2024.05.024_bib0140","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.1210\/jc.2019-00175","article-title":"A full phenotype of paraganglioma linked to a germline SDHB mosaic mutation","volume":"104","author":"Cardot-Bauters","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2024.05.024_bib0145","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1210\/jc.2007-1989","article-title":"Paraganglioma after maternal transmission of a succinate dehydrogenase gene mutation","volume":"93","author":"Pigny","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2024.05.024_bib0150","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1136\/jmedgenet-2016-104297","article-title":"Risk assessment of maternally inherited SDHD paraganglioma and phaeochromocytoma","volume":"54","author":"Burnichon","year":"2017","journal-title":"J Med Genet"},{"key":"10.1016\/j.ando.2024.05.024_bib0155","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1136\/jmedgenet-2018-105714","article-title":"Targeted next-generation sequencing detects rare genetic events in pheochromocytoma and paraganglioma","volume":"56","author":"Ben Aim","year":"2019","journal-title":"J Med Genet"},{"key":"10.1016\/j.ando.2024.05.024_bib0160","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/joim.12869","article-title":"Genetic testing and surveillance guidelines in hereditary pheochromocytoma and paraganglioma","volume":"285","author":"Muth","year":"2019","journal-title":"J Intern Med"},{"key":"10.1016\/j.ando.2024.05.024_bib0165","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrendo.2016.185","article-title":"Consensus Statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas NGS in PPGL (NGSnPPGL) Study Group","volume":"13","author":"Toledo","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.ando.2024.05.024_bib0170","doi-asserted-by":"crossref","first-page":"e220373","DOI":"10.1530\/ERC-22-0373","article-title":"Update on the genetics of paragangliomas","volume":"30","author":"Gimenez Roqueplo","year":"2023","journal-title":"Endocr Related Cancer"},{"key":"10.1016\/j.ando.2024.05.024_bib0175","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1136\/jmedgenet-2019-106214","article-title":"Variant type is associated with disease characteristics in SDHB, SDHC, and SDHD-linked pheochromocytoma-paraganglioma","volume":"57","author":"Bayley","year":"2020","journal-title":"J Med Genet"},{"key":"10.1016\/j.ando.2024.05.024_bib0180","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.3390\/genes13061025","article-title":"Hypothesis: why different types of SDH gene variants cause divergent tumor phenotypes?","volume":"13","author":"Bayley","year":"2022","journal-title":"Genes"},{"key":"10.1016\/j.ando.2024.05.024_bib0185","doi-asserted-by":"crossref","first-page":"T201","DOI":"10.1530\/ERC-18-0085","article-title":"65 YEARS OF THE DOUBLE HELIX: genetics informs precision practice in the diagnosis and management of pheochromocytoma","volume":"25","author":"Neumann","year":"2018","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ando.2024.05.024_bib0190","doi-asserted-by":"crossref","first-page":"e220167","DOI":"10.1530\/JME-22-0167","article-title":"Genetic bases of pheochromocytoma and paraganglioma","volume":"70","author":"Cascon","year":"2023","journal-title":"J Mol Endocrinol"},{"key":"10.1016\/j.ando.2024.05.024_bib0195","doi-asserted-by":"crossref","first-page":"E531","DOI":"10.1210\/jc.2014-3399","article-title":"Heterogeneous genetic background of the association of pheochromocytoma\/paraganglioma and pituitary adenoma: results from a large patient cohort","volume":"100","author":"D\u00e9nes","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2024.05.024_bib0200","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1530\/EJE-20-0054","article-title":"Germinal defects of SDHx genes in patients with isolated pituitary adenoma","volume":"183","author":"Mougel","year":"2020","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2024.05.024_bib0205","doi-asserted-by":"crossref","first-page":"E1386","DOI":"10.1210\/jc.2015-2689","article-title":"Succinate dehydrogenase (SDH)-deficient pancreatic neuroendocrine tumor expands the SDH-related spectrum","volume":"100","author":"Niemeijer","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2024.05.024_bib0210","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3390\/jcm7060116","article-title":"Functioning mediastinal paraganglioma associated with a germline mutation of VHL","volume":"7","author":"Bahougne","year":"2018","journal-title":"J Clin Med"},{"key":"10.1016\/j.ando.2024.05.024_bib0215","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S2213-8587(23)00038-4","article-title":"Clinical consensus guideline on the management of phaechromocytoma and paraganglioma in patients harbouring germline SDHD pathogenic variants","volume":"11","author":"Taieb","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.ando.2024.05.024_bib0220","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1210\/clinem\/dgad109","article-title":"Serum succinate\/fumarate ratio in patients with paraganglioma\/pheochromocytoma attending an endocrine oncogenetic unit","volume":"108","author":"Bancel","year":"2023","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426624000933?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426624000933?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T06:41:59Z","timestamp":1728456119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003426624000933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S0003426624000933"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2024.05.024","relation":{},"ISSN":["0003-4266"],"issn-type":[{"value":"0003-4266","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic predisposition to pheochromocytoma and paraganglioma: 21 years of experience in the field","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2024.05.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}